Replies to post #514895 on NorthWest Biotherapeutics Inc (NWBO)

[dr_lowenstein]

that's s big IF. any drug can look good if the data is manipulated

[Fireman02360]

But, realistically, it has to be more than $7-12.

But realistically all these numbers you are talking are just projections. NW Bio has zero drugs approved as of today, heavy debt and barely enough cash to keep the lights on. This is not a fair world or a fair playing field for these small biotechs. Being cash strapped isn't helping things. If NW Bio had $150 million in cash and less than 100 mil OS they would be in a much better position for negotiations. But this is not the case. Retail is usually wrong in these types of deals, I suspect most will be wrong again, when NW Bio is sold for around $10B.

-Fireman

[sentiment_stocks]

So to be clear, your projected price range is based on an algorithm you used for Keytruda, and then applied to Northwest, correct?

Based on that, the projected share price was $21.29 for the very conservative estimate and $64.77 for the second.

When I first read your post, I thought you meant that was your algorithm for Merck... but I was reading it quickly. :)

Would you tell me what is the time frame for this projection? Meaning... is this what you think the company share price should be worth now, or at some point in the future (and if so, about when or based on what milestone being reached)?